02 September 2022 : Clinical Research
Comparative Evaluation of 3 Commercial Mouthwash Formulations on Clinical Parameters of Chronic Gingivitis
Shahabe Saquib Abullais1ABFG, Sabiha Ilyas Patel2ADEF, Elyas Ali Asiri3ABCE, Adel Ali Ahmed Jathmi3ABE, Afnan Hassan Alkhayri3ADEG, Yosra Mohammed Mousa3BEFG, Atheer Abdulhade Ganem4BCE, Khurshid A. Mattoo5CDE*DOI: 10.12659/MSM.937111
Med Sci Monit 2022; 28:e937111
Table 1 Demographic characteristics of study participants and their distribution status between the groups.
| Parameter | Divisions | Group 1 (CHX) (n=15)n (%) | Group 2 (Manuka) (n=15)n (%) | Group 3 (ProD) (n=15)n (%) | Total | Chi square testP-value |
|---|---|---|---|---|---|---|
| Gender | Male | 8 (53.3%) | 9 (60.0%) | 7 (46.7%) | 24 | χ=0.535 (NS)P=.76501 |
| Female | 7 (46.7%) | 6 (40.0%) | 8 (53.3%) | 21 | ||
| Age | 21–25 | 3 (20.0%) | 4 (26.7%) | 5 (33.3%) | 11 | χ=0.5455 (NS)P=.9972 |
| 26–30 | 4 (26.7%) | 3 (20.0%) | 4 (26.7%) | 11 | ||
| 31–35 | 4 (26.7%) | 4 (26.7%) | 3 (20.0%) | 12 | ||
| 36–40 | 4 (26.6%) | 4 (26.6%) | 3 (20.0%) | 11 | ||
| CHX – chlorhexidine; ProD – prodental probiotic; n – number. Level of significance: NS (non-significant)=P≥0.05; * P | ||||||